Intervention

PF-00489791

ClinicalTrials.gov intervention label

Clinical trials4
Recruiting0
Common conditions5
Lead sponsors shown1

Clinical trials

4 shown
A Phase 2, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of PF-00489791 In Patients With Type 2 Diabetes And Overt NephropathyNCT01200394 · 2010-12-01
COMPLETED
PF-00489791 For The Treatment Of Raynaud'sNCT01090492 · 2010-08-04
COMPLETED
A Research Study To Assess The Effectiveness And Safety Of Different Doses Of Oral PF-00489791 In The Treatment Of Adult Patients With Pulmonary Arterial HypertensionNCT00853112 · 2009-04-01
TERMINATED
A Dose Finding Study Of PF-00489791 In Patients With Mild To Moderate High Blood PressureNCT00422461 · 2007-02-27
COMPLETED

Trial status mix

COMPLETED3
TERMINATED1

Phase mix

PHASE24

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.